))
Global Buzz: Hugel's Letybo FDA Approval in Aesthetic Medicine
Manage episode 406066745 series 3555205
Content provided by Dr Teri Fisher. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Teri Fisher or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Hugel, a global pharmaceutical company, received FDA approval for their new botulinum toxin, Letybo, marking a milestone in aesthetic medicine. Letybo offers a new option for anti-aging treatments, catering to physicians and patients seeking innovative solutions in the realm of non-surgical aesthetics. This development signifies progress in enhancing natural beauty, shaping the future of aesthetic medicine.
…
continue reading
Stay connected with Dr. Teri Fisher and keep up with the latest in aesthetic medicine:
- Visit Dr. Fisher's website for more "sculpted confidence": DrTeriFisher.com
- Follow Dr. Fisher on Instagram for more inspiration: @DrTeriFisher
- Listen to Dr. Fisher's long-form podcast: Anti-Aging Insights
- Book an appointment with Dr. Fisher: antiagingvancouver.com
👉 Don't forget to subscribe to "Aesthetic Medicine Minute" for your daily quick sip of aesthetic medicine science, and share with friends who might enjoy it too!
#AestheticMedicineMinute #DrTeriFisher
70 episodes
Share
